CALF Pacer US Small Cap Cash Cows ETF

Pacer US Small Cap Cash Cows ETF (CALF) currently reports 197 stock positions (subject to change), placing it in the broad-based range by holdings breadth. The top line-up is THC (2.74%), EXPE (2.55%), OMC (2.01%), with THC as the largest single weight at 2.74%. Together, the top three holdings account for 7.30%, which does not represent a dominant share, indicating less concentration in the very top of the book. The overall construction balances concentrated exposure at the top with broader diversification through the rest of the book.

Through the lens of capital efficiency, ROIC is 27.71%, WACC is 7.85%, and the economic spread is 19.86%. On balance, the gap between operating returns and funding costs is healthy, pointing to businesses with genuine pricing and reinvestment advantages. Supporting metrics show ROE at 43.20% and ROA at 8.10%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio with credible compounding capacity if current operating execution persists.

On a multiple basis, the portfolio trades at trailing P/E of 12.91, forward P/E of 11.15, PEG of 3.89. Forward P/E is broadly in line with trailing, suggesting analysts are not projecting a material change in profitability over the coming year. The PEG reading is high enough to suggest the market is attributing significant optionality or quality premium to the portfolio's underlying businesses. The portfolio's weighted current ratio of 2.50 reflects adequate near-term financial stability. The valuation setup is broadly consistent with a market that is pricing growth without being reckless about it — a balanced but not cautious stance.

The margin profile breaks down as follows: gross margin sits at 51.33%, operating margin at 18.58%, and free cash flow margin at 20.88%. Gross margins are in good shape, suggesting the holdings maintain pricing discipline at the revenue-to-cost interface. Operating margins are solid, reflecting adequate cost control relative to the revenue base. The portfolio's FCF margin is healthy, indicating solid cash conversion after capital expenditure needs. The mixed margin profile here calls for selectivity — the portfolio's quality of earnings is not uniform across the holding set.

The growth and outlook picture reads as follows: TTM revenue growth of 15.69% pointing to reasonable revenue execution across the underlying holdings. In parallel, analysts project moderate appreciation over the next 12 months based on current consensus targets. The gap between trailing fundamentals and forward expectations matters most at inflection points — and the current environment is not without those. For long-term holders, the central question is whether today's execution quality is a leading indicator of what's already priced into analyst targets. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

The data points reviewed collectively point toward a positive outcome if execution holds — the setup is favorable even accounting for the inherent uncertainty in forward estimates.

The views expressed above are derived from quantitative data only and should not be relied upon as financial advice. Investment decisions should be based on your own research and risk tolerance.